학술논문
P277 Long-term safety, tolerability, and efficacy of Efgartigimod in patients with Generalized Myasthenia Gravis: concluding analyses from the ADAPT+ study
Document Type
Abstract
Author
Source
In Neuromuscular Disorders October 2023 33 Supplement 1:S179-S179
Subject
Language
ISSN
0960-8966